Sanofi Sees Booster Role For Covid Vaccine After Solid But Underwhelming Results
Lower Efficacy In Older Adults
Executive Summary
Once expected to play a key role in beating COVID-19, Sanofi and GSK now see their vaccine as most likely to be used as a booster.